PlumX Metrics
Embed PlumX Metrics

Entecavir for the treatment of chronic hepatitis B virus infection

Clinical Therapeutics, ISSN: 0149-2918, Vol: 28, Issue: 2, Page: 184-203
2006
  • 68
    Citations
  • 0
    Usage
  • 74
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    68
  • Captures
    74
  • Mentions
    1
    • References
      1
      • Wikipedia
        1

Article Description

This article reviews the pharmacology/pharmacokinetics and therapeutic efficacy of entecavir, which was approved on March 29, 2005, for the management of adult patients with chronic hepatitis B virus (HBV) infection who have active viral replication and/or elevations in liver transaminases or signs of active liver disease on histologic examination. Potential drug interactions and adverse events associated with the use of entecavir are also reviewed.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know